Andrew Okun - PerkinElmer President
| PKIDelisted Stock | USD 115.24 0.74 0.64% |
President
Mr. Andrew Okun is Chief Accounting Officer, Vice President of PerkinElmer Inc., Mr. Okun joined us in 2001 and has served in financial and controllership positions of increasing responsibility, including Director of Finance for the Optoelectronics business from 2001 through 2005, Vice President of Finance from 2005 through 2009 and Vice President and Corporationrationrate Controller from 2009 through 2011. Prior to joining us, Mr. Okun most recently worked for Honeywell International as a Site Controller as well as for Coopers Lybrand since 2021.
| Age | 53 |
| Tenure | 3 years |
| Professional Marks | MBA |
| Phone | 781 663 6900 |
| Web | https://www.perkinelmer.com |
PerkinElmer Management Efficiency
The company has Return on Asset of 0.0369 % which means that on every $100 spent on assets, it made $0.0369 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0706 %, implying that it generated $0.0706 on every 100 dollars invested. PerkinElmer's management efficiency ratios could be used to measure how well PerkinElmer manages its routine affairs as well as how well it operates its assets and liabilities.PerkinElmer has 3.92 B in debt with debt to equity (D/E) ratio of 0.65, which is OK given its current industry classification. PerkinElmer has a current ratio of 1.98, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for PerkinElmer to invest in growth at high rates of return.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Mark Stevenson | Thermo Fisher Scientific | 57 | |
| Michael Lane | IDEXX Laboratories | 55 | |
| Michael Knell | Charles River Laboratories | 47 | |
| Richard III | IQVIA Holdings | 61 | |
| Robert Carson | Waters | 46 | |
| Daniel Raskas | Danaher | 54 | |
| Joakim Weidemanis | Danaher | 55 | |
| John Lynch | Waters | N/A | |
| Daniel Comas | Danaher | 55 | |
| Dominique Grau | Agilent Technologies | 65 | |
| Jacob Thaysen | Agilent Technologies | 49 | |
| Simon Holmes | ICON PLC | 57 | |
| Wendy Stewart | IQVIA Holdings | N/A | |
| Peter Wilkinson | Laboratory of | 53 | |
| Lance Berberian | Laboratory of | 61 | |
| Joseph LaPlume | Charles River Laboratories | 50 | |
| Brian Caveney | Laboratory of | 47 | |
| Sharon Underberg | IDEXX Laboratories | 63 | |
| Matthew McGrew | Danaher | 52 | |
| Walter Staub | IQVIA Holdings | 57 | |
| Michael Tang | Agilent Technologies | 50 | |
Management Performance
| Return On Equity | 0.0706 | |||
| Return On Asset | 0.0369 |
PerkinElmer Leadership Team
Elected by the shareholders, the PerkinElmer's board of directors comprises two types of representatives: PerkinElmer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PerkinElmer. The board's role is to monitor PerkinElmer's management team and ensure that shareholders' interests are well served. PerkinElmer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PerkinElmer's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joel Goldberg, Senior Vice President - Administration, General Counsel, Secretary | ||
| Samuel Chapin, Independent Director | ||
| Michel Vounatsos, Independent Director | ||
| James Mock, Chief Financial Officer, Senior Vice President | ||
| Sylvie Gregoire, Independent Director | ||
| Andrew Okun, Chief Accounting Officer, Vice President, Treasurer | ||
| Pascale Witz, Independent Director | ||
| Miriame Victor, Chief Commercial Officer, Senior Vice President | ||
| Peter Barrett, Independent Director | ||
| Deborah Butters, Chief Human Resource Officer, Senior Vice President | ||
| Frank Witney, Independent Director | ||
| Alexis Michas, Independent Non-Executive Chairman of the Board | ||
| Stephen Willoughby, VP ESG | ||
| Tajinder Vohra, Senior Vice President Global Operations | ||
| Prahlad Singh, Senior Vice President and President - Diagnostics | ||
| Robert Friel, Chairman, CEO and President and Member of Fin. Committee | ||
| Maxwell Krakowiak, VP CFO | ||
| Masoud Toloue, VP Diagnostics | ||
| Daniel Tereau, Senior Vice President Strategy and Business Development | ||
| Alexandros Michas, Independent Non-Executive Chairman of the Board |
PerkinElmer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PerkinElmer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0706 | |||
| Return On Asset | 0.0369 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 22.3 B | |||
| Shares Outstanding | 126.41 M | |||
| Shares Owned By Insiders | 0.26 % | |||
| Shares Owned By Institutions | 86.25 % | |||
| Number Of Shares Shorted | 3.53 M | |||
| Price To Earning | 21.07 X |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in PerkinElmer Stock
If you are still planning to invest in PerkinElmer check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PerkinElmer's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |